Stockreport

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings [Yahoo! Finance]

Ardelyx, Inc.  (ARDX) 
Last ardelyx, inc. earnings: 3/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ardelyx.com/investor-relations
PDF and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the company will present a post-hoc analysis of th [Read more]